chrisvoncsefalvay/vaers-outcomes huggingface dataset:
We started with a cough the night of the vaccine. The next day I started with a fever at about 10PM. Never had real serious breathing issues. The doctor did not give us anything and told us to take over the counter for the fever and cough. Eat soup and stay hydrated from our family doctor. Symptoms: we were lucky with mild symptoms for a couple days. The cough continued. A little wheezing. I'm not asthmatic in any way, but I did have some wheezing. So after we were clear from COVID, 3 weeks later, I went to the clinic because I might have had something because I no longer had COVID and I was still wheezing, coughing and having chest tightness. I went and they said it could be a sinus infection but couldn't find a reason for these symptoms. They gave me Flonase and saline solution for my nose. Gave me an inhaler for the wheezing. They also gave me benzonatate. While all of those things helped me, it didn't stop it. It was continual. That was in January. I never fully got back to normal and went back to the clinic in February. They gave me another round of what they gave me to begin with. I don't remember the antibiotic, but they gave me a 5-day course of something to try and kick this. I stayed with those mild symptoms until the beginning of March. I still have shortness of breath. A little wheezing. Tightness in the chest. I get short of breath faster than I used to. Mild symptoms still ongoing.
Patient awoke about 3am Sat (11/5) with fever, redness, swelling, stiffness (generalized), excessive urination, general flu-like symptoms - took benadryl- symptoms continued through Sunday.  Patient reports hot-flashes or flushing on Friday, possibly related, and is feeling significantly improved today.
Localized arm pain; Muscle aches; Fatigue; Vertigo; Headache; Chills; Fever; This is a spontaneous report from a contactable nurse, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202), via an unspecified route of administration in the arm left on 12Mar2021 at 09:45 (at the age of 58-year-old), as a single dose for COVID-19 immunisation. Medical history included graves disease, hypothyroidism, afib, vertigo, Hx BrCA w/chemo/radiation (breast cancer, chemotherapy, radiotherapy) and COVID-19. The patient received other vaccine (HPV vaccine VLP rL1 2v (baculovirus)) (Lot number: 95JR5), in the left arm on 12Feb2021 within four weeks prior to the vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), calcium, colecalciferol (CALCIUM AND VIT D), metoprolol succinate (METOPROLOL) and estradiol (ESTRING); all taken for unknown indication from unknown date. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 13Mar2021, at 03:00 the patient experienced localized arm pain, muscle aches, fatigue, vertigo, headache, chills and fever of 100.3 within 24 hours of vaccine. The chills and fever lasted only one day while remaining symptoms lasted 3.  The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for localized arm pain, muscle aches, fatigue, vertigo, headache, chills and fever. The clinical outcome of the events localized arm pain, muscle aches, vertigo and headache were resolved, while that of the events fatigue was resolved in Mar2021 (patient felt fatigue for one week); chills and fever was resolved on 14Mar2021 (lasted only one day).  No follow-up attempts are needed. No further information is expected.
Feelings of illness and fatigue the following day. Fever.  Day 5 severe vaginal itching treated with Diflucan.  Day 6 - vaginal itch severity increased - treated with antihistamine.  Some relief noticed within hours.
Dizziness; Back Ache; Joint Pain; Muscle Pain; Headache; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Dizziness), BACK PAIN (Back Ache), ARTHRALGIA (Joint Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L29) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DIZZINESS (Dizziness), BACK PAIN (Back Ache), ARTHRALGIA (Joint Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache). In February 2021, DIZZINESS (Dizziness), BACK PAIN (Back Ache), ARTHRALGIA (Joint Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was reported for the events. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
A 72 year old man has received several series of Tice BCG bladder installations over the past 2-3 years, for treatment of bladder cancer.  Most recently, he had been receiving "booster" installations once every 3 months.  Following the most recent installation on 12/31/2002, within less than 48 hours, he developed a rash, present "all over his body", which has persisted and actually worsened, per the patient's wife, over the following 3 weeks (as of 01/22/2003).  The patient has reportedly "tried everything" (non-prescription) for the rash, including Benadryl and topical solutions, all without relief.  He has not started taking any new medication during the time period involved.  Per the reporter, there is no evidence of  a systemic BCG infection.
6hr p/vax sore throat;several hr later fever 102.6;24hr later +nausea/vomiting;neck/shoulder pain;
Narrative: Pt received 1st vaccine on 7/21 and stated he became very sick afterwards, could not eat for 1 week, had no taste and lost about 10 lbs. Did not contact PCP and when he started feeling better it was time for second dose. Second dose was given on 8/11, pt stated felt sick again, chest pain started few days after vaccine, was tired, had no appetite, lost his energy.
patient get a flu shot and they gave her Pfizer injection she passed away; get a flu shot and they gave her Pfizer injection; get a flu shot and they gave her Pfizer injection; The initial case was missing the following minimum criteria: unidentifiable reporter. Upon receipt of follow-up information on 03Jan2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), in 2021 as dose 5 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), in 2021 as dose number unknown, single (Batch/Lot number: unknown) for influenza immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (First dose; manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Second dose; manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Third dose; manufacturer unknown), for COVID-19 Immunization; Covid-19 vaccine (Fourth dose; manufacturer unknown), for COVID-19 Immunization. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "patient get a flu shot and they gave her Pfizer injection she passed away"; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious), outcome "unknown" and all described as "get a flu shot and they gave her Pfizer injection". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: patient get a flu shot and they gave her Pfizer injection she passed away
Sneezing fit for 10 minutes, nasal congestion,  upper lip became slightly puffy and got a feeling of a lump in my throat.    Subsided over a couple hours.
Unevaluable event; COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) and UNEVALUABLE EVENT (Unevaluable event) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Hidradenitis suppurativa.    Concurrent medical conditions included Hidradenitis suppurativa (MODERATE TO SEVERE).   On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) Unknown. On 31-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced UNEVALUABLE EVENT (Unevaluable event). At the time of the report, COVID-19 (COVID-19) was resolving and UNEVALUABLE EVENT (Unevaluable event) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Jan-2022, SARS-CoV-2 test: (Positive) Positive.         No concomitant medications were reported.  On an unknown date, the patient experienced congestion. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.   The reporter's causality for the event of COVID-19 was no reasonable possibility and the reporter's causality for the event of unevaluable event was not provided with HUMIRA(ADALIMUMAB).  No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Pt got a ZOSTAVAX shot and experienced a rash and itchiness after administration. Advised follow up with doctor.
Pt received Moderna on 3/1/21 and 3/30/21. Pt was found to be COVID+ 4/6/21. Pt hospitalized on 4/6/21 for nonCOVID related issues.
Fever 104; Nauseous; Lethargic; This is a spontaneous report from a contactable consumer (wife). This consumer reported for a male (husband) patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on 20Aug2021, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not reported), via an unspecified route of administration, on an unspecified date, as a single dose for COVID-19 immunization. The reporter stated, she actually calling about her husband. He got the COVID Vaccine yesterday around 2 o'clock the Pfizer one. It was his second dose, he has started having a fever 104 and he was super nauseous and really lethargic on an unspecified date in Aug2021 and she just wanted to know if those were normal reaction. She tried calling the pharmacy, but they were closed but the people works there said to give you guys a call if there were any reaction like this. The patient underwent lab test and procedure included body temperature 104 on an unspecified date in Aug2021. Outcome of the events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be re-quested during follow up.
Pt with persistent decreased ROM and pain of L shoulder since the end of September after her flu shot.
Loud ringing in ears that has not subsided.  Visited ENT Specialist and diagnosed with Tinnitus.
Rash and itchy place below where shot is. Just starting  ice pack. Don't have Cortizone  or claritin here at present time/
Began facial swelling, cough, nasal cong & difficulty breathing 30 mins p/vax; responded to epi; PE showed wheal & flare (22x35mm) of vax inject site, no wheezing p/epi, very red lt conjunctivis; dx anaphylaxis;
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: rash on both arms.
Large red area covering most of my upper left arm.  No itching. Appeared 16 days after shot.    The  shot hurt , my arm has been very tender only at the injection site.
following morning - lost taste and smell (covid test negative) and had rash at injection site and face  -- no other systemic symptoms -
Symptoms started at 2 AM on September 29. Fever of 100.3  , headache chills.   Fever continued for 48 hours. Very lethargic and fatigued. Multiple muscle aches. Intense headache. Symptoms did not update until the morning of October 1.
This is a spontaneous report from a contactable nurse. A female patient of an unspecified age and ethnicity received PREVNAR, via an unspecified route of administration on an unspecified date as single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient previously received PNEUMOVAX and PREVNAR 13 for immunization. The patient received 2 Prevnar doses in a 10 month period of time and experienced pain and the swelling at the site on an unspecified date. Details were as follows:  patient had received pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) about 10 months ago and then received pneumococcal vaccine at a pharmacy and then a month later went back to the pharmacy and got pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein). The patient went to the hospital and was discharged with therapeutic measures for pain and the swelling at the site in form of BENADRYL; but patient said it was getting worse. The outcome of patient received 2 Prevnar doses in a 10 month period of time was unknown and the outcome of experienced pain and the swelling at the site was not recovered.
This is an instance of breakthrough COVID-19 disease after which death occurred.   The individual was vaccinated with the Moderna product on 12/24/2020 and 01/21/2021.  They became symptomatic for COVID-19 disease on 08/19/2021 and tested positive via both PCR and antigen tests on 08/19/2021. They were admitted to hospital 08/19/2021-08/24/2021, discharged to the nursing home at which they were a resident. They were then re-admitted on 08/27/2021 and discharged again to nursing home on Hospice on 08/31/2021 , after the individual declined further aggressive cares. They then died on 09/01/2021.
Patient fainted and bumped/scraped his head in the process. He came to quickly and was alert and oriented. His physical exam was normal.
No adverse event. Patient was given last years formula of flu vaccine. Upon discovery patient was notified and revaccinated with current vaccine per public Health recommendation. 2017-2018 formula was shipped to our store recently from another pharmacy med in with current 2018-2019 formula. This was not caught until after the vaccine was given in a chain of vaccinations.
Information has been received from a registered nurse concerning a female who on an unspecified date was vaccinated with a dose of GARDASIL (lot # not provided). Subsequently the patient fainted and fell off the table, scraping her face. The patient sought unspecified medical attention. At the time of the report, the patient recovered. Additional information has been requested.
Felt symptomatic 3 hours after receiving the vaccine, which I know is normal. It started with pain in the left side of my neck and shoulder, like a pulled muscle. By night, I felt like I had the flu. Flu-like symptoms were at about an 8 on a scale of 1-10. By the next morning (08/03/21), I felt like I was at a 5, so condition improved. Neck was still severely sore, I could barely move it. No injection site soreness was experienced. Flu symptoms cleared by the end of the 4th, only fatigue, malaise, and left side sensitivity remained. On the 5th, I began my menstrual cycle. It was just over a week early. I am on birth control (Nexplanon implant). I?ve been on it since October of 2019. My cycles do not occur every month anymore, they occur every other month. Pretty predictably and for my usual 6-7 days. If anything it?ll be late before it comes early. And I?m not a woman who spots in between. This cycle occurred in the month it was supposed to but came early and is still on, 15 days later. I?ve experienced heavy PMS and MS symptoms for what is normal for me. Flow repeatedly wains between light and  medium. This is not normal for me. Also not normal for me is to feel headaches and neck pain when I?m tired or stressed. Since being vaccinated, I still feel anywhere from light to severe neck pains on the side of vaccination. Sometimes it?ll last for a few minutes and sometimes hours. And it?s never a gradual arrival and departure of pain. I?ll look up and feel sore and then I?ll look up and all of a sudden, don?t need to hold my neck anymore. I?ve been taking pamprin on and off for the last two weeks to deal with the neck/body pains, and the menstrual symptoms. I don?t know if this is connected or not but I just wanted to report it anyway. I will be going to see a doctor soon to address my menstrual issue soon enough.
?Covid arm? rash 1.5 inches appeared today. Itchiness began yesterday.
Sore arm and swollen, red and rash around injection site. Didn't start until 6 days after injection
pt recvd vax;pt called md to report swelling/pain at inject site;no med prescribed;pt said pain/swelling had extended down to elbow & was warm to the touch; no fever; not seen by md;
Information has been received from a physician concerning a female with a history of unspecified hypersensitivity reactions who was recently vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the pt developed severe allergic  reaction and rash. Medical attention was sought and the pt was treated with 2 courses of unspecified therapies. The pt's outcome was unk. Additional information has been requested.
c/o pain to arm the morning after vaccines received with minimal redness around injection site; by the afternoon pt had increased swelling and redness and also c/o pain with walking; all symptoms reportedly resolved by 3-4 days after vaccine received according to Mother.
Acute hypoxemic and hypercapnic respiratory failure; COVID-19 pneumonia. Treated with BiPAP and O2 through patient's own airway.
12-29-16 Health center called an stated the patient showed up to their clinic on 12-22-16 with what appeared to be an abscess to left deltoid area.
developed a "chicken pox" rash all over her body /began on her back and progressed to trunk area and out, to hands and feet; This case was reported by a consumer via call center representative and described the occurrence of varicella-like rash in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 20th October 2020, the patient received the 1st dose of Shingrix (intramuscular). On 20th November 2020, 31 days after receiving Shingrix, the patient experienced varicella-like rash. On an unknown date, the outcome of the varicella-like rash was recovered/resolved.   It was unknown if the reporter considered the varicella-like rash to be related to Shingrix.  Additional details were provided as follows: The patient got first dose of Shingrix vaccine and less than a month after that, the patient developed a chicken pox rash all over her body. The rash began on her back and progressed to trunk area and out, to hands and feet. The patient then stated, it gradually went away in a week. When asked if she had seen her provider and was diagnosed with chicken pox, the patient stated she had not seen her provider due to covid. The patient then clarified that she developed a rash that looked like chicken pox. The patient wanted to find out if anybody else had experienced a rash and if she should get the second dose. The reporter consented to follow up.
Patient vaccinated by nurse and nurse reported patients eyes rolled back, patient appeared diaphoretic and pale Patient seen by medical team, vitals were stable, patient provided water and stated symptoms resolved Patient refused medical transport and signed AMA form
Pt recvd DTP/OPV @ 130PM on 28AUG91 & 2 hrs later the pt was brought back to the office w/urticaria of the face, trunk, & extremities; tx w/DPH; no respitatory problems noted;
pt developed a headache at the back of her head and trouble breathing (she says from wearing a facemask too long).  removed mask and gave pt facesheild.  pt states feeling of cold flush and strange smell like tires burning.  gave pt water and monitored for worsening of symptoms.  all symptoms resolved within 30 minutes.
Site: Bruising at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: brusining and swelling at injection site, counseled pt to use ice pack and to seek medical care if no improvements over the next few days
This spontaneous report was received from a registered nurse referring to multiple patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. It was reported that on 21-JUN-2016 or 22-JUN-2016, the patients received improperly stored doses of VARIVAX lot # L046888, expiration date 23-NOV-2017 (dose, dose number and anatomical location not reported) or PROQUAD lot # L051100, expiration date 17-JUN-2017 (dose, dose number and anatomical location not reported). The temperature was -7.4 C and the time frame was less than 1 hour. Concomitant medications were not reported. It was unspecified as to which product was received on which date. Additional information has been requested.
Had approximately 20 minute generalized grand mal seizure about 16 hrs after receiving PEDIARIX, HIB, and PREVNAR. Went to ER, given IV Ativan to stop seizure.  11/17/2009 ED record for 9/29-30/2009, patient with seizure activity. Tx: IV Ativan. DC DX convulsions ICD-9 code 780.39
Severe local reaction with redness, warmth, itching, and tenderness of > 15 cm diameter of the left upper thigh
pt's mom called & stated pt c/o dizziness, weakness & lt arm sl swollen & painful; no fever & no redness on arm; states has small lump; adv by RN to apply cold packs to lt arm & give analgesics; if worse go to MD for eval;moms felt had flu
2ns shot -- headache that started shortly after the shot that worsened and was not alleviated with tylenol. headache lasted about 1.5 days. chills started at about 3 am on 1/13/2021 and lasted for about 1 day. body aches lasted for one day on 1/13. fatigue started on 1/13 and lasted through 1/14. painful left axillary lymph node swelling starting on 1/13 and continuing to present day.  1st shot -- sore arm, painful left axillary lymph node swelling
7 hours post administration, patient had an anaphylactic reaction. she took liquid Benadryl, administered herself an EpiPen, used an albuterol inhaler and went to the er. Patient recovered while in the er and returned home. At pharmacy on the day of the vaccination clinic, patient stayed in a waiting area 15 mins after getting the vaccine. The way our set up was in the store, patient was sitting next to a kiwi plant in the garden and plant area. she is allergic to kiwi. patient is not certain what caused the reaction.
Redness and tenderness on the tip of my tongue ( it looks like a strawberry) it developed enlarged white bumps that hurt/burned when touched. It would also burn with toothpaste, spicy food and salty food.  It is still there 4/3/21) although the redness has lessened